Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Li-fraumeni syndrome.

Malkin D.

Genes Cancer. 2011 Apr;2(4):475-84. doi: 10.1177/1947601911413466.

2.

Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.

Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM; British Childhood Cancer Survivor Study Steering Group.

JAMA. 2011 Jun 8;305(22):2311-9. doi: 10.1001/jama.2011.747.

PMID:
21642683
3.

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.

Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW.

CA Cancer J Clin. 2011 Jan-Feb;61(1):8-30. doi: 10.3322/caac.20096. Epub 2011 Jan 4.

4.

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP.

J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95. doi: 10.1093/jnci/djq238. Epub 2010 Jul 15.

5.

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.

Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.

J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.

PMID:
20522432
6.

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1420-9. doi: 10.1016/j.ijrobp.2009.01.073.

PMID:
19931732
7.

Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.

Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S.

J Natl Cancer Inst. 2009 Jun 3;101(11):806-13. doi: 10.1093/jnci/djp104. Epub 2009 May 26.

PMID:
19470947
8.

The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK.

J Clin Oncol. 2009 May 10;27(14):2308-18. doi: 10.1200/JCO.2009.22.3339. Epub 2009 Apr 13. Review.

9.

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee.

Gastroenterology. 2008 May;134(5):1570-95. doi: 10.1053/j.gastro.2008.02.002. Epub 2008 Feb 8. Review.

PMID:
18384785
10.

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.

van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2007 Oct 1;25(28):4370-8.

PMID:
17906202
11.

Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS.

J Clin Oncol. 2006 Jan 20;24(3):476-83.

PMID:
16421424
12.

Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.

Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM.

J Clin Oncol. 2004 Dec 15;22(24):4979-90. Epub 2004 Dec 2.

PMID:
15576413
13.

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT; Late Effects Study Group.

J Clin Oncol. 2003 Dec 1;21(23):4386-94.

PMID:
14645429
14.

A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers.

Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL.

Am J Epidemiol. 2003 Dec 1;158(11):1108-13.

PMID:
14630607
15.

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C; Gastrointestinal Consortium Panel.

Gastroenterology. 2003 Feb;124(2):544-60.

PMID:
12557158
16.

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.

Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM.

Blood. 2002 Sep 15;100(6):1989-96.

17.

Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.

Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB.

J Clin Oncol. 2002 Aug 15;20(16):3484-94.

PMID:
12177110
18.

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK.

Med Pediatr Oncol. 2002 Apr;38(4):229-39.

PMID:
11920786
19.

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.

Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee.

CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80. Erratum in: CA Cancer J Clin 2001 May-Jun;51(3):150.

20.

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, Smithson WA, Robison LL.

J Clin Oncol. 2001 Jul 1;19(13):3163-72.

PMID:
11432882

Supplemental Content

Support Center